FDA Alerts
FDA Approves First Anti-Diarrheal Drug for HIV/AIDS Patients
The US Food and Drug Administration today approved Fulyzaq ( crofelemer ) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy, a combination of medicines used to treat HIV infection.
Diarrhea is experienced by many HIV/AIDS patients and is a common reason why patients discontinue or switch their antiretroviral therapies. Fulyzaq is intended to be used in HIV/AIDS patients whose diarrhea is not caused by an infection from a virus, bacteria, or parasite.
Patients take Fulyzaq two times a day to manage watery diarrhea due to the secretion of electrolytes ...
FDA approves treatment for Clostridium difficile infection
The U.S. Food and Drug Administration today approved Dificid ( fidaxomicin ) tablets for the treatment of Clostridium difficile-associated diarrhea ( CDAD ).
New Test Detecting Diarrhea-Causing Infection
The FDA has approved a test that detects an infection that causes diarrhea, other intestinal problems and sometimes death.